-
Prizidilol : analytical methods and in vitro metabolism by hepatic enzymes
-
Efavirenz pharmacogenetics and metabolic toxicity in black South Africans
-
The clinical role of therapeutic drug monitoring of antiretrovirals : a Cochrane systematic review
-
Morbidity from antiretroviral metabolic effects in Africa: The Mama Study
-
Isoniazid and acetylisoniazid urine concentrations as a maker of adherence to isoniazid preventative therapy in children
-
Pharmacogenomics and pharmacokinetics of antiretroviral drugs and their associations with metabolic complications in HIV-infected Black South Africans
-
Determinants and consequences of the pharmacokinetics of rifampicin, isoniazid, pyrazinamide and ethambutol in a cohort of tuberculosis patients
-
Determination of biomarkers for toxicity and antiretroviral adherence in hair in South African patients
-
Liver Injury in HIV-positive Patients on Antituberculosis and/or Antiretroviral Therapy – Assessing Causality
-
Pharmacokinetic profile of amodiaquine and its active metabolite desethylamodiaquine in Ghanaian patients with uncomplicated Falciparum malaria
-
Poor anticoagulation control in patients taking warfarin at a tertiary and district-level prothrombin clinic in Cape Town, South Africa
-
A critical appraisal of the clinical pharmacokinetics of isoniazid
-
Outcomes and cost-effectiveness of different models of delivery of antiretroviral therapy
-
Pharmacometric modelling to inform and improve TB and HIV treatment: Focus on drug-drug interactions and neglected populations
-
A school-based intervention for improving malaria-related knowledge and practices in Maputo Province, Mozambique : a randomised controlled trial
-
The pharmacokinetics of lopinavir in HIV-infected adults receiving rifampicin with adjusted doses of lopinavir
-
Pharmacokinetics, pharmacogenetics and optimisation of treatment with non-nucleoside reverse transcriptase inhibitors in HIV-infected African children
-
Safety and effectiveness of colistin compared with tobramycin for multi-drug resistant Acinetobacter baumannii infections
-
Determination of total, unbound, and intracellular concentrations of the antiretroviral drugs Efavirenz, Lopinavir, and Ritonavir
-
Population pharmacokinetics and pharmacokinetic-pharmacodyamic modeling of antitubercular drugs
-
Clinical, pharmacokinetic, and genetic determinants of change in serum creatinine among Southern Africans on dolutegravir based antiretroviral therapy
-
Comparison of three levels of ascertainment of antenatal medication use at Gugulethu Midwife Obstetric Unit
-
Population pharmacokinetic and pharmacodynamic modelling to improve tuberculosis treatment
-
Pharmacogenomics and pharmacokinetics of dolutegravir and tenofovir in Southern Africans living with HIV
